TMCnet News
Unum Therapeutics to Present at the Cowen and Company 37th Annual Health Care ConferenceUnum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that President and Chief Executive Officer Chuck Wilson will present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017 at 4:00pm ET. The conference is being held at the Boton Marriott Copley Place in Boston, MA. About Unum Therapeutics Unum Therapeutics uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology in combination with tumor-targeting antibodies, which is designed to activate the body's own immune system to fight cancer. Unum is actively building a pipeline of ACTR programs in which proprietary, tumor-targeting antibodies are armed to improve their therapeutic potential. The Company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com/.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170227005692/en/ |
